Early Aggressive Treatment

Early aggressive treatment applies to the strategy of treating MS with an aggressive treatment to prevent potential damage, as soon as possible after the onset of the disease. This strategy is viewed as being riskier than using 1st-line DMTs that are safer, but less, effective than treatments used for early aggressive treatment. The data from this survey was used as part of a presentation at the European Charcot Foundation Meeting in Spain on the 29th November to the 1st December 2012. I would now like to expand this survey so that I can use the data as part of a presentation to the European Medicines Agency on the 17th October 2013.
    This is a required question
    This is a required question
    This is a required question
    This is a required question

    Disclaimer

    No personal identifiers, including your computer's IP address, will be collected as part of this survey. Please note that by completing this survey you are consenting to the data you provide being analysed by Prof. Giovannoni and his collaborators. Results of this survey will be presented on this blog and may be submitted for publication.